Brain metastases as site of first and isolated recurrence of breast cancer: the role of systemic therapy after local treatment.

about

Brain metastases as site of first and isolated recurrence of breast cancer: the role of systemic therapy after local treatment.

Item

http://www.wikidata.org/entity/Q48713634

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Brain metastases as site of fi ...... therapy after local treatment.

@en

Brain metastases as site of fi ...... therapy after local treatment.

@nl

type

Item

label

Brain metastases as site of fi ...... therapy after local treatment.

@en

Brain metastases as site of fi ...... therapy after local treatment.

@nl

prefLabel

Brain metastases as site of fi ...... therapy after local treatment.

@en

Brain metastases as site of fi ...... therapy after local treatment.

@nl

P1476

Brain metastases as site of fi ...... therapy after local treatment.

@en

P2093

Anna Niwińska

http://www.w3.org/2001/XMLSchema#string

P2860

Brain metastases in breast cancer

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†

Recommendations on disease management for patients with advanced human epidermal growth factor receptor 2-positive breast cancer and brain metastases: American Society of Clinical Oncology clinical practice guideline.

DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis.

Evidence-based clinical practice parameter guidelines for the treatment of patients with metastatic brain tumors: introduction

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases.

New breast cancer recursive partitioning analysis prognostic index in patients with newly diagnosed brain metastases.

Factors influencing survival in patients with breast cancer and single or solitary brain metastasis.

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.

Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study.

P2888

s10585-016-9802-1

P304

677-685

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10585-016-9802-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27225754

http://www.w3.org/2001/XMLSchema#string